Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Fam Cancer. 2014 Dec;13(4):573–582. doi: 10.1007/s10689-014-9744-1

Fig. 1.

Fig. 1

Prostate carcinoma from carrier #4 who had a pathogenic germline mutation in MSH2 (MSH2 del × 1–8). a Hematoxylin and eosin stained sections showing Gleason 8 adenocarcinoma with tumor infiltrating lymphocytes; b and c Immunohistochemistry showing normal nuclear expression of MLH1 in tumor cells (b) and loss of nuclear expression of MSH2 in tumor cells (c). All images magnification ×400